Home

Arthur Bruce Cohen

CIK 1343780 · last filed 2021-04-22

Arthur Bruce Cohen is a corporate insider who has filed 11 SEC Form 4 insider transactions across 3 companies since 2008. Across all open-market trades the lifetime net is +$60.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.06M

Companies

3

Total Filings

11

Lifetime Open-Market Net

$60.95M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EHTH 10%+ Owner 2,252,119 $1.36 $3.06M -$8.09M 1 2013-02-15
MAGELLAN HEALTH INC (MGLN) Delisted 2,500,000 $94.99 $237.47M -$72.80M 1 2011-12-07
VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted 10%+ Owner 10,000,000 — — $141.84M 1 2008-10-31

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-04-22 — Grant (A) — $0
2020-07-02 — Grant (A) — $0
2015-10-02 — Grant (A) — $0
2015-02-19 — Grant (A) — $0
2014-07-01 — Grant (A) — $0
2013-02-15 EHTH Sell (S) −317,358 -$8.09M EDGAR
2012-10-02 — Grant (A) — $0
2011-12-07 MAGELLAN HEALTH INC (MGLN) Delisted Sell (S) −1,500,000 -$72.80M EDGAR
2009-01-29 — Mixed — $0
2008-10-31 VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted Buy (P) +9,000,000 $141.84M EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.